Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.0300 (-1.54%) ($6.8800 - $7.1900) on Mon. Sep. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.29% (three month average) | RSI | 53 | Latest Price | $7.0300(-1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(6%) EWG(4%) TBT(4%) URA(4%) IBUY(3%) | Factors Impacting CGEN price | CGEN will decline at least -1.145% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) BNDX(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.145% (StdDev 2.29%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $7.12(-1.26%) | 10 Day Moving Average | $7.1(-0.99%) | 20 Day Moving Average | $7.01(0.29%) | To recent high | -5.1% | To recent low | 11.6% | Market Cap | $581m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |